1. Scrip
  2. >>Business
  3. >>Deals

Deal Watch: Molecular Templates Aligns With Vertex On Optimizing Stem Cell Candidates

 
• By Joseph Haas and Eleanor Malone

Alliance with Molecular Templates may help advance efforts under Vertex’s existing collaboration with CRISPR Therapeutics. Dragonfly’s latest partner for its TriNKET platform is AbbVie.

DealWatch_1200x675

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions.

Molecular Templates Inc. and Vertex Pharmaceuticals Inc. penned an agreement on 18 November for the discovery and development...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business